AI is transforming how patients search for health information, how brands communicate, and how trust is built in healthcare.

In this episode of The Patient Experience Podcast, Bob Miglani is joined by Dan Seewald, former Head of Worldwide Innovation at Pfizer, TED Talk keynote speaker, and Founder of Deliberate Innovation. Dan is also the Co-Founder and CEO of LiviWell, a FemTech medical device company, and brings deep experience helping organizations solve complex challenges through design thinking, AI, and rapid problem solving.

Together, they explore how AI is redefining pharma marketing, from faster content creation and AI-driven insights to true personalization and shifting from one-to-many to highly targeted, trust-based engagement. They also unpack the growing patient confusion crisis and what pharma leaders must do to educate patients more effectively in a Direct to Patient world.

This episode is for pharma brand leaders, patient services teams, and marketers looking to apply AI in a practical, meaningful way.

Learn more about Dan Seewald at www.deliberateinnovation.net or connect with him on LinkedIn.

The Patient Experience Podcast explores how pharma patient services leaders and patient-facing teams can navigate a growing patient confusion crisis as therapies become more complex and the industry moves Direct to Patient. Hosted by Jason Grossman, a 25-year pharma commercial, patient services, and marketing executive, and Bob Miglani, former Pfizer leader and CEO of Hoot, each episode delivers practical insights leaders can use and reps can apply in the field to better educate patients, build trust, and drive better outcomes.

New episodes are recorded live on Bob Miglani’s LinkedIn and published across major podcast platforms.

Follow the hosts:
Bob Miglani on LinkedIn
Jason Grossman on LinkedIn

Learn more at GetHoot.com.

The patient journey has changed dramatically over the past decade. What was once a straightforward path from diagnosis to prescription has evolved into a much more complex experience involving genetic testing, specialist referrals, insurance approvals, specialty pharmacies, and an overwhelming amount of information online.

In this episode of The Patient Experience Podcast, hosts Bob Miglani and Jason Grossman explore how the patient journey is evolving and why this shift is creating what they describe as a growing patient confusion crisis. As therapies become more specialized and personalized, physicians have less time to guide patients through increasingly complicated decisions. At the same time, patients are turning to AI tools, social media, and online communities for answers, often leaving them overwhelmed or misinformed.

Bob and Jason discuss the forces driving these changes, including the rise of direct-to-patient healthcare models, new pricing transparency initiatives, and the rapid growth of rare disease and specialty therapies. They also explore what this means for pharmaceutical leaders, patient services teams, and patient-facing organizations that are working to help patients start therapy, stay on treatment, and make informed decisions.

For pharma leaders navigating this new landscape, understanding how the patient journey has evolved is essential to building trust, improving education, and delivering a better patient experience.

The Patient Experience Podcast explores how pharma patient services leaders and patient-facing teams can navigate a growing patient confusion crisis as therapies become more complex and the industry moves Direct to Patient. Hosted by Jason Grossman, a 25-year pharma commercial, patient services, and marketing executive, and Bob Miglani, former Pfizer leader and CEO of Hoot, each episode delivers practical insights leaders can use and reps can apply in the field to better educate patients, build trust, and drive better outcomes.

New episodes are recorded live on Bob Miglani’s LinkedIn and published across major podcast platforms.

Follow the hosts:
Bob Miglani on LinkedIn
Jason Grossman on LinkedIn

Learn more at GetHoot.com.

In this first episode of The Patient Experience Podcast, Bob Miglani and Jason Grossman examine the rapid shift toward Pharma Direct to Patient and why it’s fueling a growing patient confusion crisis. As therapies become more specialized and disease education more complex, patients are leaving appointments overwhelmed, misinformed, and unsure what to do next.

They discuss how limited physician time, rising misinformation, and increasingly complex treatment pathways are impacting therapy starts, adherence, and patient trust. The conversation explores where patient services is headed next and why education, clarity, and HCP-led guidance are becoming critical as decisions move beyond the clinic and into the home.

This episode is for pharma leaders, patient services and engagement teams, brand leaders, and patient-facing teams navigating what comes next in a Direct to Patient world.

The Patient Experience Podcast explores how pharma patient services leaders and patient-facing teams can navigate a growing patient confusion crisis as therapies become more complex and the industry moves Direct to Patient. Hosted by Jason Grossman, a 25-year pharma commercial, patient services, and marketing executive, and Bob Miglani, former Pfizer leader and CEO of Hoot, each episode delivers practical insights leaders can use and reps can apply in the field to better educate patients, build trust, and drive better outcomes.

New episodes are recorded live on Bob Miglani’s LinkedIn and published across major podcast platforms.

Follow the hosts:
Bob Miglani on LinkedIn
Jason Grossman on LinkedIn

Learn more at GetHoot.com.